STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Myriad Genetics (NASDAQ:MYGN), a molecular diagnostic testing and precision medicine company, announced its participation in two upcoming healthcare investor conferences. Management will present at the Wells Fargo Healthcare Conference on September 4, 2025, at 3:45 PM ET and the Morgan Stanley Annual Global Healthcare Conference on September 10, 2025, at 7:45 AM ET. Both presentations will be available via webcast on the company's investor relations website.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

SALT LAKE CITY, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced Myriad management will participate in two upcoming healthcare conferences.

  • The Wells Fargo Healthcare Conference with a fireside chat on Thursday, Sept. 4 at 3:45pm ET.
  • The Morgan Stanley Annual Global Healthcare Conference with a fireside chat on Wednesday, Sept. 10 at 7:45am ET.

Links to the live and archived webcasts of both presentations can be viewed at investor.myriad.com.

About Myriad Genetics
Myriad Genetics is a leading molecular diagnostic testing and precision medicine company dedicated to advancing health and well-being for all. Myriad Genetics develops and offers molecular tests that help assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where molecular insights can significantly improve patient care and lower healthcare costs. For more information, visit www.myriad.com.

Investor Contact 
Matt Scalo 
(801) 584-3532 
IR@myriad.com 

Media Contact 
Kate Schraml
(224) 875-4493 
PR@myriad.com


FAQ

When is Myriad Genetics (MYGN) presenting at the Wells Fargo Healthcare Conference 2025?

Myriad Genetics will present at the Wells Fargo Healthcare Conference on September 4, 2025, at 3:45 PM ET.

What time is Myriad Genetics presenting at the Morgan Stanley Healthcare Conference 2025?

Myriad Genetics will present at the Morgan Stanley Annual Global Healthcare Conference on September 10, 2025, at 7:45 AM ET.

How can investors access Myriad Genetics' (MYGN) conference presentations?

Investors can access both the live and archived webcasts of the presentations through Myriad Genetics' investor relations website at investor.myriad.com.

Which investor conferences is Myriad Genetics (MYGN) attending in September 2025?

Myriad Genetics is attending two conferences: the Wells Fargo Healthcare Conference on September 4 and the Morgan Stanley Annual Global Healthcare Conference on September 10, 2025.
Myriad Genetics

NASDAQ:MYGN

MYGN Rankings

MYGN Latest News

MYGN Latest SEC Filings

MYGN Stock Data

737.32M
90.13M
2.9%
98.4%
9.66%
Diagnostics & Research
In Vitro & in Vivo Diagnostic Substances
Link
United States
SALT LAKE CITY